Albuterol Sulfate

Albuterol Sulfate

Albuterol Sulfate Recall

Get an alert when a recall is issued.

Questions & Answers

Side Effects & Adverse Reactions

Paradoxical Bronchospasm

Albuterol tablets can produce paradoxical bronchospasm, which may be life threatening. If paradoxical bronchospasm occurs, albuterol tablets should be discontinued immediately and alternative therapy instituted.

Cardiovascular Effects

Albuterol tablets, like all other beta-adrenergic agonists, can produce a clinically significant cardiovascular effect in some patients as measured by pulse rate, blood pressure, and/or symptoms. Although such effects are uncommon after administration of albuterol tablets at recommended doses, if they occur, the drug may need to be discontinued. In addition, beta-agonists have been reported to produce electrocardiogram (ECG) changes, such as flattening of the T wave, prolongation of the QTc interval, and ST segment depression. The clinical significance of these findings is unknown. Therefore, albuterol tablets, like all sympathomimetic amines, should be used with caution in patients with cardiovascular disorders, especially coronary insufficiency, cardiac arrhythmias, and hypertension.

Deterioration of Asthma

Asthma may deteriorate acutely over a period of hours or chronically over several days or longer. If the patient needs more doses of albuterol tablets than usual, this may be a marker of destabilization of asthma and requires reevaluation of the patient and treatment regimen, giving special consideration to the possible need for anti-inflammatory treatment, e.g., corticosteroids.

Use of Anti-Inflammatory Agents

The use of beta-adrenergic agonist bronchodilators alone may not be adequate to control asthma in many patients. Early consideration should be given to adding anti-inflammatory agents, e.g., corticosteroids.

Immediate Hypersensitivity Reactions

Immediate hypersensitivity reactions may occur after administration of albuterol, as demonstrated by rare cases of urticaria, angioedema, rash, bronchospasm, and oropharyngeal edema. Albuterol, like other beta-adrenergic agonists, can produce a significant cardiovascular effect in some patients, as measured by pulse rate, blood pressure, symptoms, and/or electrocardiographic changes.

Rarely, erythema multiforme and Stevens-Johnson syndrome have been associated with the administration of oral albuterol sulfate in children.

Legal Issues

There is currently no legal information available for this drug.

FDA Safety Alerts

There are currently no FDA safety alerts available for this drug.

Manufacturer Warnings

There is currently no manufacturer warning information available for this drug.

FDA Labeling Changes

There are currently no FDA labeling changes available for this drug.

Uses

Albuterol tablets are indicated for the relief of bronchospasm in adults and children 6 years of age and older with reversible obstructive airway disease.

History

There is currently no drug history available for this drug.

Other Information

Albuterol tablets contain albuterol sulfate, USP, the racemic form of albuterol and a relatively selective beta2-adrenergic bronchodilator. Albuterol sulfate has the chemical name α1-[(tert-Butylamino)methyl]-4-hydroxy-m-xylene-α,α'-diol sulfate (2:1)(salt) and the following structural formula:

Albulterol Structural Formula

Albuterol sulfate has a molecular weight of 576.71, and the molecular formula is (C13H21NO3)2•H2SO4. Albuterol sulfate is a white or practically white powder, freely soluble in water and slightly soluble in ethanol.

The World Health Organization recommended name for albuterol base is salbutamol.

Each albuterol sulfate tablet, for oral administration contains 2 or 4 mg of albuterol as 2.4 or 4.8 mg of albuterol sulfate, respectively. Each tablet also contains the following inactive ingredients: anhydrous lactose, magnesium stearate, pregelatinized (corn) starch, and sodium starch glycolate.

Albuterol Sulfate Manufacturers


  • American Health Packaging
    Albuterol Sulfate Tablet [American Health Packaging]
  • Actavis Mid Atlantic Llc
    Albuterol Sulfate (Albuterol Sulfate) Inhalant [Actavis Mid Atlantic Llc]
  • Actavis Mid Atlantic Llc
    Albuterol Sulfate (Albuterol Sulfate) Syrup [Actavis Mid Atlantic Llc]
  • Bausch & Lomb Incorporated
    Albuterol Sulfate (Albuterol Sulfate) Solution [Bausch & Lomb Incorporated]
  • Bryant Ranch Prepack
    Albuterol Sulfate Tablet [Bryant Ranch Prepack]
  • Physicians Total Care, Inc.
    Albuterol Sulfate Tablet [Physicians Total Care, Inc.]
  • Bryant Ranch Prepack
    Albuterol Sulfate Tablet [Bryant Ranch Prepack]
  • Remedyrepack Inc.
    Albuterol Sulfate Tablet [Remedyrepack Inc. ]
  • Remedyrepack Inc.
    Albuterol Sulfate Tablet [Remedyrepack Inc. ]
  • Mylan Pharmaceuticals Inc.
    Albuterol Sulfate Tablet, Film Coated, Extended Release [Mylan Pharmaceuticals Inc.]
  • Mutual Pharmaceutical Company, Inc.
    Albuterol Sulfate Tablet [Mutual Pharmaceutical Company, Inc.]
  • Preferred Pharmaceuticals, Inc.
    Albuterol Sulfate Tablet [Preferred Pharmaceuticals, Inc.]
  • American Health Packaging
    Albuterol Sulfate Tablet [American Health Packaging]

Login To Your Free Account